Publications
March 5, 2024
Workflow to facilitate the detection of new psychoactive substances and drugs of abuse in influent urban wastewater
Bade R, van Herwerden D, Rousis N, Adhikari S, Allen D, Baduel C, Bijlsma L, Boogaerts T, Burgard D, Chappell A, Driver EM, Sodre FF, Fatta-Kassinos D Gracia-Lor E, Gracia-Marín E, Halden RU, Heath E, Jaunay E, Krotulski A, Lai FY, ... Mueller J
Journal of Hazardous Materials
February 28, 2024
Evaluating cross-reactivity of new psychoactive substances (NPS) in human whole blood by enzyme-linked immunosorbent assay (ELISA)
February 27, 2024
Detection of xylazine in whole blood samples using high resolution mass spectrometry
February 23, 2024
Determination of fentanyl contamination on United States paper currency by LC-QQQ-MS
February 16, 2024
Wastewater-based monitoring of the nitazene analogues: First detection of protonitazene in wastewater
Bade R, Nadarajan D, Driver EM, Halden RU, Gerber C, Krotulski AJ, Hall W, Mueller JF
Science of The Total Environment
February 1, 2024
Notes from the Field: Cluster of Severe Illness from Neptune’s Fix Tianeptine Linked to Synthetic Cannabinoids — New Jersey, June–November 2023
Counts CJ, Spadaro AV, Cerbini TA, Krotulski AJ, Greller HA, Nelson LS, Ruck BE, Calello DP
Morbidity and Mortality Weekly Report (MMWR)
November 30, 2023
Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5-bromo-indazole-3-carboxamide synthetic cannabinoid receptor agonists
Norman C, Webling K, Kyslychenko O, Reid R, Krotulski AJ, Farrell R, Deventer MH, Liu H, Connolly MJ, Guillou C, Vinckier IMJ, Logan BK, NicDaéid N, McKenzie C, Stove CP, Gréen
Drug Testing and Analysis
August 29, 2023
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients
Nmaducci A, Aldy K, Campleman SL, Li S, Meyn A, Abston S, Culbreth, Krotulski AJ, Logan BK, Wax P, Brent J, Manini AF, for the Toxicology Investigators Consortium Fentalog Study Group
JAMA Network Open
July 25, 2023
In vitro cannabinoid receptor activity, metabolism, and detection in seized samples of CH-PIATA, a new indole-3-acetamide synthetic cannabinoid
Norman C, Deventer MH, Dremann O, Reid R, Van Uytfanghe K, Guillou C, Vinckier IMJ, Daéid NN, Krotulski AJ, Stove CP
Drug Testing and Analysis
July 11, 2023
